Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)
about
Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell linesCurrent progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents.Mitotic entry: Non-genetic heterogeneity exposes the requirement for Plk1.Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.Small molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury.Recent Advances and New Strategies in Targeting Plk1 for Anticancer TherapyApplications of Palladium-Catalyzed C-N Cross-Coupling Reactions.Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1.A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.Monitoring and inhibition of Plk1: amphiphilic porphyrin conjugated Plk1 specific peptides for its imaging and anti-tumor function.
P2860
Q27334288-FF7D2DB4-3235-45D8-94E3-D03EDC488DA9Q33873351-BB276933-9C7E-4C69-915B-AC5DDC6DFCB6Q35809557-B03FE0C0-1D90-4FFE-AB6D-193F7AEB3B8EQ35957698-3EA28312-FA5B-44D4-A451-2E4DB2DCB487Q35968088-F721CB14-900A-4B95-B2A0-A71E3411B744Q36386336-E69D223C-FA63-47D1-A2A5-5912705F76B1Q38968855-504D95F6-EBE4-48F4-A930-2DE1F960BF1EQ46311028-67B95E0E-F597-45D9-8C98-B8917F7897D9Q48243218-012E25BB-340C-422E-9A6D-D2933F6D3191Q54341332-0AC021E6-8650-4509-9CC4-86C944AE13A8
P2860
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@ast
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@en
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@nl
type
label
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@ast
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@en
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@nl
prefLabel
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@ast
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@en
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@nl
P2093
P3181
P356
P1476
Discovery of a potent and oral ...... f Polo-like kinase 1 (MLN0905)
@en
P2093
Bheemashankar Kulkarni
Courtney Cullis
Cynthia Barrett
David Janowick
Debra Liao
Denise L Driscoll
Dominic J Reynolds
Douglas Bowman
P304
P3181
P356
10.1021/JM2011172
P407
P577
2012-01-12T00:00:00Z